News Chart IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Delayed Nasdaq Stockholm Other stock markets 03:18:54 2024-05-21 am EDT			5-day change	1st Jan Change
15.85 ^SEK	+1.60%		-2.16%	+111.33%

May. 08	Transcript : IRLAB Therapeutics AB, Q1 2024 Earnings Call, May 08, 2024
May. 07	IRLAB Therapeutics AB and McQuade Center for Strategic Research and Development, LLC Enter into Development Collaboration for IRL757 as Novel Treatment for Apathy	CI

15e8a650ebfc161fc39.Epf3vvOkXHx67YrhdN06ZcYhbaYtdOZ3p2Qb_KPgi6E.ca68ipb0MSYKoMSHIIpjC_ERBddpLq8fwzRBtMWL7clb0sXJsJMLNUnbww~52515e606326a9a713c0402855c04a95